The ovine cytotoxic T lymphocyte responses to bluetongue virus

Research in Veterinary Science

Volumn 67, Issue 3, 1999, Pages 213-221

  Janardhana, V ^a   Andrew, M E ^a   Lobato, Z I P ^a,b   Coupar, B E H ^a  

^a CSIRO   (Australia)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSID PROTEIN; NS1 PROTEIN, BLUETONGUE VIRUS; VIRUS ANTIGEN; VIRUS PROTEIN; VP2 PROTEIN, BLUETONGUE VIRUS;

ANIMAL; ANIMAL DISEASE; ARTICLE; BLUETONGUE ORBIVIRUS; CELL LINE; CYTOTOXIC T LYMPHOCYTE; EPITOPE MAPPING; IMMUNOLOGY; PEPTIDE MAPPING; SHEEP; VACCINIA VIRUS; VIROLOGY; VIRUS CAPSID;

ANIMALS; ANTIGENS, VIRAL; BLUETONGUE VIRUS; CAPSID; CAPSID PROTEINS; CELL LINE; EPITOPE MAPPING; PEPTIDE MAPPING; SHEEP; T-LYMPHOCYTES, CYTOTOXIC; VACCINIA VIRUS; VIRAL NONSTRUCTURAL PROTEINS;

EID: 0033256656     PISSN: 00345288     EISSN: None     Source Type: Journal    
DOI: 10.1053/rvsc.1999.0306     Document Type: Article

References (24)

1. ANDREW, M. E., COUPAR, B. E. H., ADA, G. L. & BOYLE, D. B. (1986) Cell-mediated immune responses to influenza virus antigens expressed by vaccinia virus recombinants. Microbial Pathogenesis 1, 443-452
2. ANDREW, M., WHITELEY, P., JANARDHANA, V., LOBATO, Z., GOULD, A. & COUPAR, B. (1995) Antigen specificity of the ovine cytotoxic T lymphocyte response to bluetongue virus. Veterinary Immunology and Immunopathology 47, 311-322
3. BOYLE, D. B., COUPAR, B. E. H. & BOTH, G. W. (1985) Multiple-cloning-site plasmids for the rapid construction of recombinant poxviruses. Gene 35, 169-177
4. BURROWS, S. R., SCULLEY, T. B., MISKO, I. S., SCHMIDT, M. C. & MOSS, D. J. (1990) An Epstein-Barr virus-specific cytotoxic T cell epitope in EBV nuclear antigen 3 (EBNA 3). Journal of Experimental Medicine 171, 345-349
5. DAVISON, A. J. & MOSS, B. (1990) New vaccinia virus recombination plasmids incorporating a synthetic late promoter for high expression of foreign proteins. Nucleic Acids Research 18, 4285-4286
6. DE CAMPOS-LIMA, P. O., LEVITSKY, V., BROOKS, J., LEE, S. P., HU, L. F., RICKINSON, A. B. & MASUCCI, M. G. (1994) T cell responses and virus evolution: loss of HLA A11-restricted CTL epitopes in Epstein-Barr virus isolates from highly A11-positive populations by selective mutation of anchor residues. Journal of Experimental Medicine 179, 1297-1305
7. DOEL, T. R., GALE, C., BROOKE, G. & DIMARCHE, R. (1988) Immunization against foot-and-mouth disease with synthetic peptides representing the C-terminal region of VP1. Journal of General Virology 69, 2403-2406
8. EATON, B. T., GOULD, A. R., HYATT, A. D., COUPAR, B. E. H., MARTYN, J. C. AND WHITE, J. R. (1991) A bluetongue serogroup-reactive epitope in the amino terminal half of the major core protein VP7 is accessible on the surface of bluetongue virus particles. Virology 180, 687-696
9. EATON, B. T., HYATT, A. D. & WHITE, J. R. (1988) Localization of the nonstructural protein NS1 in bluetongue virus-infected cells and its presence in virus particles. Virology 163, 527-537
10. HYATT, A. D., GOULD, A. R., COUPAR, B. & EATON, B. T. (1991) Localization of the non-structural protein NS3 in bluetongue virus-infected cells. Journal of General Virology 72, 2263-2267
11. ISSEKUTZ, T. B. (1984) Kinetics of cytotoxic lymphocytes in efferent lymph from single lymph nodes following immunization with vaccinia virus. Clinical and Experimental Immunology 56, 515-523
12. JEGGO, M. H., WARDLEY, R. C. & BROWNLIE, J. (1985) Importance of ovine cytotoxic T cells in protection against bluetongue virus infection. In Bluetongue and related orbiviruses. Eds. T. L. Barber & M. M. Jochim, New York, Alan R. Liss., pp. 477-487
13. KAGEYAMA, S., TSOMIDES, T. J., SYKULEV, Y. & EISEN, H. N. (1995) Variations in the number of peptide-MHC class I complexes required to activate cytotoxic T cell responses. Journal of Immunology 154, 567-576
14. KHANNA, R., BURROWS, S. R. & MOSS, D. J. (1995) Immune regulation in Epstein-Barr virus-associated diseases. Microbiological Reviews 59, 387-405
15. LOBATO, Z. I. P., COUPAR, B. E. H., GRAY, C. P., LUNT, R. & ANDREW, M. E. (1997) Antibody responses and protective immunity to recombinant vaccinia virus-expressed bluetongue virus antigens. Veterinary Immunology and Immunopathology 59, 293-309
16. MERTENS, P. P. C., BURROUGHS, J. N. & ANDERSON, J. (1987) Purification and properties of virus particles, infectious subviral particles, and cores of bluetongue virus serotypes 1 and 4. Virology 157, 375-386
17. OFFIT, P. A., COUPAR, B. E. H., SVOBODA, Y. M., JENKINS, R. J., MCCRAE, M. A., ABRAHAM, A., HILL, N. L., BOYLE, D. B., ANDREW, M. E. & BOTH, G. W. (1994) Induction of rotavirus-specific cytotoxic T lymphocytes by vaccinia virus recombinants expressing individual rotavirus genes. Virology 198, 10-16
18. OUTTERIDGE, P. M., CULLEN, P. R., WINDON, R. G. & BROWN, S. (1988) Ovine lymphocyte antigens: a comparison of Australian and European antisera. Animal Genetics 19, 159-169
19. PAULY, T., ELBERS, K., KONIG, M., LENGSFELD, T., SAALMULLER, A. & THIEL, H.-J. (1995) Classical swine fever virus-specific cytotoxic T lymphocytes and identification of a T cell epitope. Journal of General Virology 76, 3039-3049
20. SWEETSER, M. T., BRACIALE, V. L. & BRACIALE, T. J. (1988) Class I MHC-restricted recognition of cells expressing a gene encoding a 41 amino acid product of the influenza hemagglutinin. Journal of Immunology 141, 3324-3328
21. TAKAMATSU, H. & JEGGO, M. H. (1989) Cultivation of bluetongue virus-specific ovine T cells and their cross-reactivity with different serotype viruses. Immunology 66, 258-263
22. THOMSON, S. A., ELLIOTT, S. L., SHERRITT, M. A., SPROAT, K. W., COUPAR, B. E. H., SCALZO, A. A., FORBES, C. A., LADHAMS, A. M., MO, X. Y., TRIPP, R. A., DOHERTY, P. C., MOSS, D. J. & SUHRBIER, A. (1996) Recombinant polyepitope vaccines for the delivery of multiple CD8 cytotoxic T cells epitopes. Journal of Immunology 157, 822-826
23. TOWNSEND, A., BASTIN, J., GOULD, K., BROWNLEE, G., ANDREW, M., COUPAR, B., BOYLE, D., CHAN, S. & SMITH, G. (1988) Defective presentation to class I-restricted cytotoxic T lymphocytes in vaccinia-infected cells is overcome by enhanced degradation of antigen. Journal of Experimental Medicine 168, 1211-1224
24. WILLE, A., GESSNER, A., LOTHER, H. & LEHMANN-GRUBE, F. (1989) Mechanism of recovery from acute virus infection. VIII. Treatment of lymphocytic choriomeningitis virus-infected mice with anti-interferon-g monoclonal antibody blocks generation of virus-specific cytotoxic T lymphocytes and virus elimination. European Journal of Immunology 19, 1283-1288